vs
Axil Brands, Inc.(AXIL)与Foghorn Therapeutics Inc.(FHTX)财务数据对比。点击上方公司名可切换其他公司
Foghorn Therapeutics Inc.的季度营收约是Axil Brands, Inc.的1.1倍($9.2M vs $8.1M),Axil Brands, Inc.净利率更高(8.7% vs -234.3%,领先242.9%),Foghorn Therapeutics Inc.同比增速更快(223.8% vs 5.2%),过去两年Foghorn Therapeutics Inc.的营收复合增速更高(35.3% vs 12.1%)
Axil Brands是一家总部位于美国的专业消费电子企业,主营高端听力防护设备、音频增强装置及个性化音频配件,旗下产品涵盖定制耳塞、运动蓝牙耳机等,面向全球普通消费者及专业作业群体销售。
Foghorn Therapeutics是一家临床阶段生物技术企业,专注于开发靶向染色质调控系统的创新疗法,用于治疗多种癌症及其他严重疾病,目前推进多款靶向候选药物管线,通过自主研发与战略合作服务全球患者群体。
AXIL vs FHTX — 直观对比
营收规模更大
FHTX
是对方的1.1倍
$8.1M
营收增速更快
FHTX
高出218.6%
5.2%
净利率更高
AXIL
高出242.9%
-234.3%
两年增速更快
FHTX
近两年复合增速
12.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $8.1M | $9.2M |
| 净利润 | $704.9K | $-21.7M |
| 毛利率 | 68.1% | — |
| 营业利润率 | 11.1% | -258.2% |
| 净利率 | 8.7% | -234.3% |
| 营收同比 | 5.2% | 223.8% |
| 净利润同比 | 11.2% | -11.1% |
| 每股收益(稀释后) | $0.09 | $-0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AXIL
FHTX
| Q4 25 | $8.1M | $9.2M | ||
| Q3 25 | $6.9M | $8.2M | ||
| Q2 25 | $5.8M | $7.6M | ||
| Q1 25 | $6.9M | $6.0M | ||
| Q4 24 | $7.7M | $2.9M | ||
| Q3 24 | $5.9M | $7.8M | ||
| Q2 24 | $6.5M | $6.9M | ||
| Q1 24 | $6.5M | $5.0M |
净利润
AXIL
FHTX
| Q4 25 | $704.9K | $-21.7M | ||
| Q3 25 | $334.3K | $-15.8M | ||
| Q2 25 | $-245.6K | $-17.9M | ||
| Q1 25 | $576.7K | $-18.8M | ||
| Q4 24 | $633.7K | $-19.5M | ||
| Q3 24 | $-109.8K | $-19.1M | ||
| Q2 24 | $49.5K | $-23.0M | ||
| Q1 24 | $781.1K | $-25.0M |
毛利率
AXIL
FHTX
| Q4 25 | 68.1% | — | ||
| Q3 25 | 67.6% | — | ||
| Q2 25 | 70.0% | — | ||
| Q1 25 | 71.7% | — | ||
| Q4 24 | 71.1% | — | ||
| Q3 24 | 71.0% | — | ||
| Q2 24 | 71.5% | — | ||
| Q1 24 | 71.5% | — |
营业利润率
AXIL
FHTX
| Q4 25 | 11.1% | -258.2% | ||
| Q3 25 | 6.0% | -226.9% | ||
| Q2 25 | 0.8% | -279.2% | ||
| Q1 25 | 8.4% | -385.0% | ||
| Q4 24 | 8.7% | -840.5% | ||
| Q3 24 | -2.4% | -305.5% | ||
| Q2 24 | 2.6% | -386.6% | ||
| Q1 24 | -1.6% | -558.3% |
净利率
AXIL
FHTX
| Q4 25 | 8.7% | -234.3% | ||
| Q3 25 | 4.9% | -194.4% | ||
| Q2 25 | -4.3% | -237.3% | ||
| Q1 25 | 8.3% | -316.4% | ||
| Q4 24 | 8.2% | -682.9% | ||
| Q3 24 | -1.9% | -244.9% | ||
| Q2 24 | 0.8% | -333.6% | ||
| Q1 24 | 12.1% | -495.4% |
每股收益(稀释后)
AXIL
FHTX
| Q4 25 | $0.09 | $-0.35 | ||
| Q3 25 | $0.04 | $-0.25 | ||
| Q2 25 | $-0.03 | $-0.28 | ||
| Q1 25 | $0.07 | $-0.30 | ||
| Q4 24 | $0.08 | $-0.23 | ||
| Q3 24 | $-0.02 | $-0.31 | ||
| Q2 24 | $0.11 | $-0.45 | ||
| Q1 24 | $0.04 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $5.0M | $80.9M |
| 总债务越低越好 | $138.3K | — |
| 股东权益账面价值 | $11.1M | $-108.5M |
| 总资产 | $16.2M | $198.1M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势,按日历期对齐
现金及短期投资
AXIL
FHTX
| Q4 25 | $5.0M | $80.9M | ||
| Q3 25 | $4.1M | $89.3M | ||
| Q2 25 | $4.8M | $72.6M | ||
| Q1 25 | $4.7M | $61.0M | ||
| Q4 24 | $5.2M | $55.5M | ||
| Q3 24 | $4.1M | $57.7M | ||
| Q2 24 | $3.3M | $138.9M | ||
| Q1 24 | $4.9M | $79.3M |
总债务
AXIL
FHTX
| Q4 25 | $138.3K | — | ||
| Q3 25 | $139.2K | — | ||
| Q2 25 | $140.2K | — | ||
| Q1 25 | $141.0K | — | ||
| Q4 24 | $143.3K | — | ||
| Q3 24 | $144.3K | — | ||
| Q2 24 | $146.6K | — | ||
| Q1 24 | — | — |
股东权益
AXIL
FHTX
| Q4 25 | $11.1M | $-108.5M | ||
| Q3 25 | $10.2M | $-89.7M | ||
| Q2 25 | $9.7M | $-76.7M | ||
| Q1 25 | $9.7M | $-61.7M | ||
| Q4 24 | $8.8M | $-45.5M | ||
| Q3 24 | $7.9M | $-28.3M | ||
| Q2 24 | $7.7M | $-14.3M | ||
| Q1 24 | $8.8M | $-97.5M |
总资产
AXIL
FHTX
| Q4 25 | $16.2M | $198.1M | ||
| Q3 25 | $15.4M | $205.0M | ||
| Q2 25 | $12.9M | $226.2M | ||
| Q1 25 | $13.0M | $258.7M | ||
| Q4 24 | $13.7M | $284.0M | ||
| Q3 24 | $11.4M | $308.4M | ||
| Q2 24 | $11.0M | $328.6M | ||
| Q1 24 | $12.7M | $255.0M |
负债/权益比
AXIL
FHTX
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $934.8K | $-22.3M |
| 自由现金流经营现金流 - 资本支出 | $906.4K | — |
| 自由现金流率自由现金流/营收 | 11.1% | — |
| 资本支出强度资本支出/营收 | 0.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.33× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
AXIL
FHTX
| Q4 25 | $934.8K | $-22.3M | ||
| Q3 25 | $-739.2K | $-18.9M | ||
| Q2 25 | $194.4K | $-21.0M | ||
| Q1 25 | $-169.9K | $-24.0M | ||
| Q4 24 | $1.0M | $-24.5M | ||
| Q3 24 | $897.3K | $-21.0M | ||
| Q2 24 | $-336.6K | $-25.5M | ||
| Q1 24 | $-912.8K | $-29.3M |
自由现金流
AXIL
FHTX
| Q4 25 | $906.4K | — | ||
| Q3 25 | $-747.6K | — | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | $-258.2K | $-24.0M | ||
| Q4 24 | $941.1K | $-25.0M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | $-394.9K | $-25.6M | ||
| Q1 24 | $-922.1K | $-29.4M |
自由现金流率
AXIL
FHTX
| Q4 25 | 11.1% | — | ||
| Q3 25 | -10.9% | — | ||
| Q2 25 | — | -278.2% | ||
| Q1 25 | -3.7% | -403.2% | ||
| Q4 24 | 12.2% | -875.3% | ||
| Q3 24 | — | -273.0% | ||
| Q2 24 | -6.1% | -371.0% | ||
| Q1 24 | -14.3% | -583.1% |
资本支出强度
AXIL
FHTX
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | 1.3% | 0.5% | ||
| Q4 24 | 0.9% | 16.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | 0.9% | 0.2% | ||
| Q1 24 | 0.1% | 2.0% |
现金转化率
AXIL
FHTX
| Q4 25 | 1.33× | — | ||
| Q3 25 | -2.21× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.29× | — | ||
| Q4 24 | 1.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.80× | — | ||
| Q1 24 | -1.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
FHTX
暂无分部数据